Literature DB >> 20421695

Severe motor neuron degeneration in the spinal cord of the Tg2576 mouse model of Alzheimer disease.

Ji-Seon Seo1, Yea-Hyun Leem, Kang-Woo Lee, Seung-Woo Kim, Ja-Kyeong Lee, Pyung-Lim Han.   

Abstract

The transgenic mouse Tg2576 is widely used as a murine model of Alzheimer's disease (AD) and exhibits plaque pathogenesis in the brain and progressive memory impairments. Here we report that Tg2576 mice also have severe spinal cord deficits. At 10 months of age, Tg2576 mice showed a severe defect in the hindlimb extension reflex test and abnormal body trembling and hindlimb tremors when suspended by the tail. The frequency and severity of these abnormalities were overt at 10 months of age and became gradually worsened. On the foot-printing analysis, Tg2576 mice had shorter and narrower strides than the non-transgenic control. Histological analyses showed that neuronal cells including cholinergic neurons in the lumbar cord of Tg2576 mice were severely reduced in number. At 16 months of age, Tg2576 mice showed high levels of amyloid-beta accumulation in the spinal cord. Consistent with this, Tg2576 mice showed that lipid peroxidation levels were increased and mitochondrial metabolic activity were significantly reduced in the spinal cord. Administration of curcumin, a natural compound that has antioxidant properties, notably reversed motor function deficits of Tg2576 mice. The enhanced lipid peroxidation and neuronal loss in the lumbar cord was also partially suppressed by curcumin. Electron microscopic analysis revealed that the sciatic nerve fibers were severely reduced in number and were demyelinated in Tg2576 mice, which were partially rescued by curcumin. These results showed that Tg2576 mice display severe degeneration of motor neurons in the spinal cord and associated motor function deficits.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20421695     DOI: 10.3233/JAD-2010-091528

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  22 in total

Review 1.  Neuroprotective strategies involving ROS in Alzheimer disease.

Authors:  Magali Dumont; M Flint Beal
Journal:  Free Radic Biol Med       Date:  2010-12-01       Impact factor: 7.376

2.  Evaluation of spinal cord motor function in Alzheimer's disease using electrophysiological techniques indicates association of acetylcholine receptors with the disease.

Authors:  Li Yang; Chunxia Li; Xiuying Chen; Jie Wang; Shanshan Gao; Liling Yang; Yunxia Zhao; Hua Wang; Yifeng Du
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Amyloid plaque pathogenesis in 5XFAD mouse spinal cord: retrograde transneuronal modulation after peripheral nerve injury.

Authors:  Jian-Ming Li; Zhi-Qin Xue; Si-Hao Deng; Xue-Gang Luo; Peter R Patrylo; Gregory W Rose; Huaibin Cai; Yan Cai; Xiao-Xin Yan
Journal:  Neurotox Res       Date:  2012-10-05       Impact factor: 3.911

Review 4.  Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis.

Authors:  Thomas L Platt; Valerie L Reeves; M Paul Murphy
Journal:  Biochim Biophys Acta       Date:  2013-04-22

5.  Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiology.

Authors:  Daniel C Cole; Youngcheul Chung; Khatuna Gagnidze; Kaitlyn H Hajdarovic; Violeta Rayon-Estrada; Dewi Harjanto; Benedetta Bigio; Judit Gal-Toth; Teresa A Milner; Bruce S McEwen; F Nina Papavasiliou; Karen Bulloch
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-22       Impact factor: 11.205

6.  Early manifestation of gait alterations in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Anna Csiszar; Zoltan Ungvari; Stefano Tarantini; Adam Nyul-Toth; Jordan DelFavero; Peter Mukli; Amber Tarantini; Anna Ungvari; Andriy Yabluchanskiy
Journal:  Geroscience       Date:  2021-06-23       Impact factor: 7.713

Review 7.  Modeling mitochondrial dysfunctions in the brain: from mice to men.

Authors:  Megan E Breuer; Peter H G M Willems; Frans G M Russel; Werner J H Koopman; Jan A M Smeitink
Journal:  J Inherit Metab Dis       Date:  2011-07-14       Impact factor: 4.982

Review 8.  Pleiotropic protective effects of phytochemicals in Alzheimer's disease.

Authors:  Sergio Davinelli; Nadia Sapere; Davide Zella; Renata Bracale; Mariano Intrieri; Giovanni Scapagnini
Journal:  Oxid Med Cell Longev       Date:  2012-05-28       Impact factor: 6.543

9.  Rosmarinic Acid Alleviates Neurological Symptoms in the G93A-SOD1 Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Ji-Seon Seo; Juli Choi; Yea-Hyun Leem; Pyung-Lim Han
Journal:  Exp Neurobiol       Date:  2015-08-31       Impact factor: 3.261

Review 10.  Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders.

Authors:  Zhibin Liang; Antonio Currais; David Soriano-Castell; David Schubert; Pamela Maher
Journal:  Pharmacol Ther       Date:  2020-11-20       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.